SECsense Logo

ABVC Biopharma 8-K Report: Key Updates as of January 6, 2025

$ABVC
Form 8-K
Filed on: 2025-01-06
Source
ABVC Biopharma 8-K Report: Key Updates as of January 6, 2025

Here are the key pieces of information extracted from the provided section of the financial report:

  1. Entity Information:
  • Name: ABVC Biopharma, Inc.
  • CIK (Central Index Key): 0001173313
  • SEC File Number: 001-40700
  • EIN (Employer Identification Number): 26-0014658
  • Address: 44370 Old Warm Springs Blvd., Fremont, CA 94538
  • Phone Number: 510-668-0881
  1. Filing Details:
  • Form Type: 8-K (Current Report)
  • Filing Date: January 6, 2025
  • Period Covered: January 6, 2025 (as of this date)
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: ABVC
  • Exchange: NASDAQ
  1. Measurement Units:
  • Currency: USD (U.S. Dollars)
  • Shares: The report measures financial data in shares and USD per share.
  1. Context Information:
  • Context ID: AsOf2025-01-06

Insights:

  • This report is a current report (8-K) filed by ABVC Biopharma, indicating that it may involve significant events or changes pertinent to the company as of January 6, 2025.
  • The company operates in the biotech sector, as implied by its name, which may attract investors interested in innovative healthcare solutions.
  • The low par value of the common stock suggests that the company may be in a developmental stage or has a strategy to issue shares at minimal initial pricing to raise capital.
  • The listing on NASDAQ indicates a level of credibility and compliance with regulatory standards, which is essential for investor confidence.
  • The specified contact information allows investors and stakeholders to reach out for additional inquiries or clarifications regarding the report.

This summary provides a snapshot of the company's current situation as reported in the SEC filing.